跳至主要内容
临床试验/EUCTR2009-016678-34-GB
EUCTR2009-016678-34-GB进行中(未招募)1 期

Exploring the Relationship Between Insulin Resistance and Interferon Resistance: Options to Overcome HCV Non-Response to Pegylated Interferon - The Relationship Between Insulin Resistance and Interferon resistance

Imperial College London0 个研究点目标入组 22 人开始时间: 2010年3月17日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Chronic HCV genotype 1 infection
  • 2.Chronic HCV and compensated liver cirrhosis who failed to respond to previous treatment.
  • 2.Age >17, <70
  • 3.Eligible for interferon therapy
  • Are the trial subjects under 18?
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years)
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.HIV or HBV co-infection.
  • 2.Current use antidiabetic medication (eg insulin, metformin or thiazolidinedione).
  • 3.Significant respiratory, cardiac or renal dysfunction
  • 4.Body Mass Index > 30 kg/m2
  • 5. Patients with manifestations of hepatic impairment in form of hepatic decompensation. This include any patient with:
  • ?Clinically: history of ascites, jaundice, hepatic encephalopathy or bleeding oesophageal varices
  • ?Laboratory: prolonged prothrombin time, low albumin level (<33 g/l) or high billirubin level.
  • ?Imaging: evidence of ascites by abdominal ultrasound

研究者

相似试验